WinterMETozenTN. Phenytoin. In: EvansWESchentagJJJuskoWJ. Applied pharmacokinetics: Principles of therapeutic drug monitoring. 2nd ed. Spokane, WA: Applied Therapeutics, 1986: 493–539.
2.
LevineMChangT. Therapeutic drug monitoring of phenytoin. Rationale and current status. Clin Pharmacokinet1990; 19: 341–58.
3.
NationRLEvansAMMilneRW. Pharmacokinetic drug interactions with phenytoin (part 2). Clin Pharmacokinet1990; 18: 131–50.
4.
Tizanidine.Drug interview-form sheet. Tokyo, Japan: Sandos Yakuhin, 1989: 13–4.
5.
HeazlewoodVSymoniwPMaruffPEadieMJ. Tizanidine—initial pharmacokinetic studies in patients with spasticity. Eur J Clin Pharmacol1983; 25: 65–7.
6.
SayersACBurkiHREichenbergerE. The pharmacology of 5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole (DS 103–282), a novel myotonolytic agent. Arzneimittelforschung1980; 30: 793–803.
